The critical role of CD133 + CD44 +/high tumor cells in hematogenous metastasis of liver cancers

Ying Hou,Qifei Zou,Ruiliang Ge,Feng Shen,Yizheng Wang
DOI: https://doi.org/10.1038/cr.2011.139
IF: 44.1
2011-01-01
Cell Research
Abstract:Metastatic hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide. However, the cell population responsible for its metastasis remains largely unknown. Here, we reported that CD133 + CD44 +/high defined a subgroup of tumor cells that was responsible for hematogenous metastasis of liver cancers. Immunohistochemical investigation of human HCC specimens revealed that the number of CD133 + and CD44 + HCC cells was increased and was associated with portal vein invasion. Purified CD133 + or CD44 high HCC cells were superior in clonogenic growth and vascular invasion, respectively. Thus, the combination of CD133 and CD44 was used to define a novel HCC sub-population. CD133 + CD44 high , but not CD133 + CD44 low/− , CD133 − CD44 high or CD133 − CD44 low/− xenografts, produced intrahepatic or lung metastasis in nude mice. Further analysis of human HCC samples by flow cytometry showed that the number of CD133 + CD44 + tumor cells was associated with portal vein metastasis. The cDNA microarray analysis of CD133 + CD44 + and CD133 + CD44 − tumor cells isolated from metastatic HCC patients revealed that these cells comprised of two different populations possessing distinct gene expression profiles. Our results suggest that CD133 + CD44 + tumor cells are a particular population responsible for hematogenous metastasis in liver cancers and that these cells might be targets for treatment of HCC metastasis.
What problem does this paper attempt to address?